Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hang Ma

Showing results (321-330 of 328) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 328 results.
Nature Communications|August 20, 2025
Versatile photonic frequency synthetic dimensions using a single programmable on-chip deviceZhao-An Wang, Xiao-Dong Zeng, Yi-Tao Wang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 15, 2023
Synthesis, <i>in silico</i> modelling, and <i>in vitro</i> biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agentsSamuel T Boateng, Tithi Roy, Kara Torrey, et al.
Acta Pharmacologica Sinica|January 28, 2023
Long-term passaging of pseudo-typed SARS-CoV-2 reveals the breadth of monoclonal and bispecific antibody cocktailsHang Ma, Hui-Fang Zong, Jun-Jun Liu, et al.
Light, Science & Applications|April 24, 2026
A hybrid-frequency programmable synthetic-dimension simulator with rich coupling on a single chipXiao-Dong Zeng, Zhao-An Wang, Jia-Ming Ren, et al.
Thoracic Cancer|January 18, 2018
Multicenter study of diagnostic procedures, genetic aberration analysis, and first-line treatment of lung cancer in Jiangsu Province, ChinaYangBo Hu, Huan Hu, LiYun Miao, et al.
EMBO Molecular Medicine|March 6, 2020
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemiaBai-Liang He, Ning Yang, Cheuk Him Man, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2025
Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineeringYunji Liao, Hang Ma, Zhenyu Wang, et al.
Cell Discovery|February 16, 2022
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBDHang Ma, Yingying Guo, Haoneng Tang, et al.
Pageof 33

Showing results (321-330 of 328) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 328 results.
Nature Communications|August 20, 2025
Versatile photonic frequency synthetic dimensions using a single programmable on-chip deviceZhao-An Wang, Xiao-Dong Zeng, Yi-Tao Wang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 15, 2023
Synthesis, <i>in silico</i> modelling, and <i>in vitro</i> biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agentsSamuel T Boateng, Tithi Roy, Kara Torrey, et al.
Acta Pharmacologica Sinica|January 28, 2023
Long-term passaging of pseudo-typed SARS-CoV-2 reveals the breadth of monoclonal and bispecific antibody cocktailsHang Ma, Hui-Fang Zong, Jun-Jun Liu, et al.
Light, Science & Applications|April 24, 2026
A hybrid-frequency programmable synthetic-dimension simulator with rich coupling on a single chipXiao-Dong Zeng, Zhao-An Wang, Jia-Ming Ren, et al.
Thoracic Cancer|January 18, 2018
Multicenter study of diagnostic procedures, genetic aberration analysis, and first-line treatment of lung cancer in Jiangsu Province, ChinaYangBo Hu, Huan Hu, LiYun Miao, et al.
EMBO Molecular Medicine|March 6, 2020
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemiaBai-Liang He, Ning Yang, Cheuk Him Man, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2025
Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineeringYunji Liao, Hang Ma, Zhenyu Wang, et al.
Cell Discovery|February 16, 2022
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBDHang Ma, Yingying Guo, Haoneng Tang, et al.
Pageof 33